Joseph R Scarpa1, Mena Fatma2, Yong-Hwee E Loh3, Said Romaric Traore2, Theo Stefan2, Ting Huei Chen2, Eric J Nestler4, Benoit Labonté5. 1. Department of Anesthesiology, Weill Cornell Medicine, New York, New York. 2. Department of Psychiatry and Neurosciences, Laval University, Québec, Québec, Canada. 3. Norris Medical Library, University of Southern California, Los Angeles, California. 4. Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York. 5. Department of Psychiatry and Neurosciences, Laval University, Québec, Québec, Canada. Electronic address: benoit.labonte@fmed.ulaval.ca.
Abstract
BACKGROUND: Most of our knowledge of the biological basis of major depressive disorder (MDD) is derived from studies of chronic stress models in rodents. While these models capture certain aspects of the behavioral and neuroendocrine features of MDD, the extent to which they reproduce the molecular pathology of the human syndrome remains unknown. METHODS: We systematically compared transcriptional signatures in two brain regions implicated in depression-medial prefrontal cortex and nucleus accumbens-of humans with MDD and of 3 chronic stress models in mice: chronic variable stress, adult social isolation, and chronic social defeat stress. We used differential expression analysis combined with weighted gene coexpression network analysis to create interspecies gene networks and assess the capacity of each stress paradigm to recapitulate the transcriptional organization of gene networks in human MDD. RESULTS: Our results show significant overlap between transcriptional alterations in medial prefrontal cortex and nucleus accumbens in human MDD and the 3 mouse chronic stress models, with each of the chronic stress paradigms capturing distinct aspects of MDD abnormalities. Chronic variable stress and adult social isolation better reproduce differentially expressed genes, while chronic social defeat stress and adult social isolation better reproduce gene networks characteristic of human MDD. We also identified several gene networks and their constituent genes that are most significantly associated with human MDD and mouse stress models. CONCLUSIONS: This study demonstrates the ability of 3 chronic stress models in mice to recapitulate distinct aspects of the broad molecular pathology of human MDD, with no one mouse model apparently better than another.
BACKGROUND: Most of our knowledge of the biological basis of major depressive disorder (MDD) is derived from studies of chronic stress models in rodents. While these models capture certain aspects of the behavioral and neuroendocrine features of MDD, the extent to which they reproduce the molecular pathology of the human syndrome remains unknown. METHODS: We systematically compared transcriptional signatures in two brain regions implicated in depression-medial prefrontal cortex and nucleus accumbens-of humans with MDD and of 3 chronic stress models in mice: chronic variable stress, adult social isolation, and chronic social defeat stress. We used differential expression analysis combined with weighted gene coexpression network analysis to create interspecies gene networks and assess the capacity of each stress paradigm to recapitulate the transcriptional organization of gene networks in humanMDD. RESULTS: Our results show significant overlap between transcriptional alterations in medial prefrontal cortex and nucleus accumbens in humanMDD and the 3 mousechronic stress models, with each of the chronic stress paradigms capturing distinct aspects of MDD abnormalities. Chronic variable stress and adult social isolation better reproduce differentially expressed genes, while chronic social defeat stress and adult social isolation better reproduce gene networks characteristic of humanMDD. We also identified several gene networks and their constituent genes that are most significantly associated with humanMDD and mousestress models. CONCLUSIONS: This study demonstrates the ability of 3 chronic stress models in mice to recapitulate distinct aspects of the broad molecular pathology of humanMDD, with no one mouse model apparently better than another.
Authors: Holly J Carlisle; Tinh N Luong; Andrew Medina-Marino; Leslie Schenker; Eugenia Khorosheva; Tim Indersmitten; Keith M Gunapala; Andrew D Steele; Thomas J O'Dell; Paul H Patterson; Mary B Kennedy Journal: J Neurosci Date: 2011-11-09 Impact factor: 6.167
Authors: Pawel Lisowski; Grzegorz R Juszczak; Joanna Goscik; Marek Wieczorek; Lech Zwierzchowski; Artur H Swiergiel Journal: Eur Neuropsychopharmacol Date: 2010-10-20 Impact factor: 4.600
Authors: Vaishnav Krishnan; Ming-Hu Han; Danielle L Graham; Olivier Berton; William Renthal; Scott J Russo; Quincey Laplant; Ami Graham; Michael Lutter; Diane C Lagace; Subroto Ghose; Robin Reister; Paul Tannous; Thomas A Green; Rachael L Neve; Sumana Chakravarty; Arvind Kumar; Amelia J Eisch; David W Self; Francis S Lee; Carol A Tamminga; Donald C Cooper; Howard K Gershenfeld; Eric J Nestler Journal: Cell Date: 2007-10-19 Impact factor: 41.582
Authors: Tracy L Bale; Ted Abel; Huda Akil; William A Carlezon; Bita Moghaddam; Eric J Nestler; Kerry J Ressler; Scott M Thompson Journal: Neuropsychopharmacology Date: 2019-05-02 Impact factor: 7.853
Authors: Bin Zhang; Chris Gaiteri; Liviu-Gabriel Bodea; Zhi Wang; Joshua McElwee; Alexei A Podtelezhnikov; Chunsheng Zhang; Tao Xie; Linh Tran; Radu Dobrin; Eugene Fluder; Bruce Clurman; Stacey Melquist; Manikandan Narayanan; Christine Suver; Hardik Shah; Milind Mahajan; Tammy Gillis; Jayalakshmi Mysore; Marcy E MacDonald; John R Lamb; David A Bennett; Cliona Molony; David J Stone; Vilmundur Gudnason; Amanda J Myers; Eric E Schadt; Harald Neumann; Jun Zhu; Valur Emilsson Journal: Cell Date: 2013-04-25 Impact factor: 41.582
Authors: Alexander Z Harris; Piray Atsak; Zachary H Bretton; Emma S Holt; Raisa Alam; Mitchell P Morton; Atheir I Abbas; E David Leonardo; Scott S Bolkan; René Hen; Joshua A Gordon Journal: Neuropsychopharmacology Date: 2017-11-01 Impact factor: 7.853
Authors: Rosemary C Bagot; Hannah M Cates; Immanuel Purushothaman; Zachary S Lorsch; Deena M Walker; Junshi Wang; Xiaojie Huang; Oliver M Schlüter; Ian Maze; Catherine J Peña; Elizabeth A Heller; Orna Issler; Minghui Wang; Won-Min Song; Jason L Stein; Xiaochuan Liu; Marie A Doyle; Kimberly N Scobie; Hao Sheng Sun; Rachael L Neve; Daniel Geschwind; Yan Dong; Li Shen; Bin Zhang; Eric J Nestler Journal: Neuron Date: 2016-05-12 Impact factor: 17.173
Authors: Zachary A Cordner; Seva G Khambadkone; Shanshan Zhu; Justin Bai; R Rasadokht Forti; Ethan Goodman; Kellie L K Tamashiro; Christopher A Ross Journal: Complex Psychiatry Date: 2021-08-03
Authors: Shirelle X Liu; Mari S Gades; Yayi Swain; Aarthi Ramakrishnan; Andrew C Harris; Phu V Tran; Jonathan C Gewirtz Journal: Drug Alcohol Depend Date: 2021-02-13 Impact factor: 4.492
Authors: Mark David Tricklebank; Trevor W Robbins; Camilla Simmons; Erik H F Wong Journal: Psychopharmacology (Berl) Date: 2021-03-10 Impact factor: 4.530